Klenza Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 11 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -8.04%
(FY 2023)
- Ebitda -8.04%
(FY 2023)
- Net Worth -3.05%
(FY 2023)
- Total Assets 4.84%
(FY 2023)
About Klenza Life Sciences
The Corporate was formerly known as Klenza Lifesciences Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Madathetu Vijayan, Mohan Madathedattu, Rajeev Nair, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73200KA2013PTC072565
- Company No.
072565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Klenza Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Madathedattu  | Managing Director | 17-Dec-2013 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madathetu Vijayan | Director | 17-Dec-2013 | Current |
| Rajeev Nair | Director | 14-Oct-2020 | Current |
| Ganesh Srinivasan | Director | 14-Oct-2020 | Current |
| Siddarth Kumar | Director | 14-Oct-2020 | Current |
Financial Performance of Klenza Life Sciences.
Klenza Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 8.04% decrease in profit. The company's net worth dipped by a decrease of 3.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Klenza Life Sciences?
In 2023, Klenza Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Resil Chemicals Private LimitedActive 33 years 8 monthsMadathetu Vijayan, Mohan Madathedattu and 3 more are mutual person
N9 World Technologies Private LimitedActive 14 years 10 monthsMadathetu Vijayan, Mohan Madathedattu and 2 more are mutual person
- Vista Innovations Private LimitedActive 3 years 6 months
Madathetu Vijayan, Mohan Madathedattu and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Klenza Life Sciences?
Unlock and access historical data on people associated with Klenza Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klenza Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klenza Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
